Q: Hi 5i,
In your opinion, did CHR's recent quarterly report justify the significant drop in share price, and is there any sensible reason to think it might recover to at least where it was recently ($3.30 range) any time soon, or would you expect it to pretty much stay flat?
Sign me: wondering if I should have ignored the analysts who thought the name had legs and sold sooner.
Thanks.
In your opinion, did CHR's recent quarterly report justify the significant drop in share price, and is there any sensible reason to think it might recover to at least where it was recently ($3.30 range) any time soon, or would you expect it to pretty much stay flat?
Sign me: wondering if I should have ignored the analysts who thought the name had legs and sold sooner.
Thanks.